The pharmaceutical sector is seeing a significant shift in diabetes care with the arrival of GLP-1 patches. These revolutionary delivery systems offer a potentially simple alternative to injections for individuals dealing with diabetes mellitus type 2. By circumventing the need for frequent pokes, GLP-1 adhesives promise to enhance user adherence a